Spatial CRISPR screening confirmed tumor-facilitating effects of immune checkpoints (PD-L1 and CD47), and also identifies tumor composition, organization, and immune infiltration in the TME, following Socs1 and TGFBR2 KO lesion. This evidence concerns the gene CD274 and neoplasm.